Clinical Trial Update: Prospective Post Y90 Liver Hypertrophy

View source ↗

Summary

A clinical trial update on prospective post-Yttrium-90 therapy aimed at liver hypertrophy in hepatocellular carcinoma patients; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Hypertrophy

Drugs mentioned

• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: Singapore General Hospital | Conditions: Hepatocellular Carcinoma, Liver Hypertrophy | Status: UNKNOWN